Sílvia Cabrera
YOU?
Author Swipe
View article: O-058 Long-term anatomical and functional outcomes following laparoscopic repair of severe cesarean scar defect
O-058 Long-term anatomical and functional outcomes following laparoscopic repair of severe cesarean scar defect Open
Study question Does laparoscopic repair provide durable long-term anatomical, clinical, and reproductive outcomes for patients with severe cesarean scar defects over extended follow-up? Summary answer Long-term laparoscopic repair achieves…
View article: Low anterior resection syndrome in patients undergoing bowel segmental resection for rectosigmoid endometriosis: A retrospective long‐term follow‐up study
Low anterior resection syndrome in patients undergoing bowel segmental resection for rectosigmoid endometriosis: A retrospective long‐term follow‐up study Open
Aim The aim of this work was to evaluate the prevalence of low anterior resection syndrome (LARS) and its long‐term evolution following colorectal segmental resection for deep infiltrating endometriosis (DIE) and identify any associated ri…
View article: Data from Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF
Data from Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF Open
Purpose:Cervical cancer is a viral-associated tumor caused by the infection with the human papilloma virus. Cervical cancer is an immunogenic cancer that expresses viral antigens. Despite being immunogenic, cervical cancer does not fully r…
View article: Supplementary Data 1 from Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF
Supplementary Data 1 from Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF Open
Figure S1, Figure S2, Figure S3, Figure S4, Figure S5, Figure S6, Table S1, Supplementary methods
View article: Screening Strategies to Improve Early Diagnosis in Endometrial Cancer
Screening Strategies to Improve Early Diagnosis in Endometrial Cancer Open
Endometrial cancer is the most common gynecological malignancy in high-income countries and the sixth most common cancer in women. Overall incidence has risen in the last few decades as a consequence of the increase in the prevalence of it…
View article: ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS THE CLINICAL APPLICATION
ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS THE CLINICAL APPLICATION Open
Introduction In the past years, there has been a rise on advanced endometrial cancers (EC) patients resulting in mortality increase. To overcome this trend, it is essential to improve the stratification of the risk of post-surgery recurren…
View article: Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer
Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer Open
View article: Lymphovascular Space Invasion in Early-Stage Endometrial Cancer (LySEC): Patterns of Recurrence and Predictors. A Multicentre Retrospective Cohort Study of the Spain Gynecologic Oncology Group
Lymphovascular Space Invasion in Early-Stage Endometrial Cancer (LySEC): Patterns of Recurrence and Predictors. A Multicentre Retrospective Cohort Study of the Spain Gynecologic Oncology Group Open
The main aim is to compare oncological outcomes and patterns of recurrence of patients with early-stage endometrioid endometrial cancer according to lymphovascular space invasion (LVSI) status. The secondary objective is to determine preop…
View article: Supplementary Table 2 from Analysis of Gene Expression Regulated by the <i>ETV5</i> Transcription Factor in OV90 Ovarian Cancer Cells Identifies <i>FOXM1</i> Overexpression in Ovarian Cancer
Supplementary Table 2 from Analysis of Gene Expression Regulated by the <i>ETV5</i> Transcription Factor in OV90 Ovarian Cancer Cells Identifies <i>FOXM1</i> Overexpression in Ovarian Cancer Open
PDF file - 25K, Clinicopathological description of ovarian tumor samples used for quantitative PCR analysis of FoxM1 and ETV5
View article: Supplementary Table 2 from Analysis of Gene Expression Regulated by the <i>ETV5</i> Transcription Factor in OV90 Ovarian Cancer Cells Identifies <i>FOXM1</i> Overexpression in Ovarian Cancer
Supplementary Table 2 from Analysis of Gene Expression Regulated by the <i>ETV5</i> Transcription Factor in OV90 Ovarian Cancer Cells Identifies <i>FOXM1</i> Overexpression in Ovarian Cancer Open
PDF file - 25K, Clinicopathological description of ovarian tumor samples used for quantitative PCR analysis of FoxM1 and ETV5
View article: Supplementary Table 1 from Analysis of Gene Expression Regulated by the <i>ETV5</i> Transcription Factor in OV90 Ovarian Cancer Cells Identifies <i>FOXM1</i> Overexpression in Ovarian Cancer
Supplementary Table 1 from Analysis of Gene Expression Regulated by the <i>ETV5</i> Transcription Factor in OV90 Ovarian Cancer Cells Identifies <i>FOXM1</i> Overexpression in Ovarian Cancer Open
PDF file - 24K, Clinicopathological description of ovarian tumor samples used for microarray analysis
View article: Supplementary Table 1 from Analysis of Gene Expression Regulated by the <i>ETV5</i> Transcription Factor in OV90 Ovarian Cancer Cells Identifies <i>FOXM1</i> Overexpression in Ovarian Cancer
Supplementary Table 1 from Analysis of Gene Expression Regulated by the <i>ETV5</i> Transcription Factor in OV90 Ovarian Cancer Cells Identifies <i>FOXM1</i> Overexpression in Ovarian Cancer Open
PDF file - 24K, Clinicopathological description of ovarian tumor samples used for microarray analysis
View article: 6P Unveiling the impact of intra-tumor heterogeneity in treatment response to achieve personalized medicine for endometrial cancer patients
6P Unveiling the impact of intra-tumor heterogeneity in treatment response to achieve personalized medicine for endometrial cancer patients Open
Mortality in patients with high-risk and recurrent endometrial cancer (EC) is high since treatment options are limited, and tumors are extremely chemoresistant. In this study, we unveil the possible impact of molecular ITH in treatment res…
View article: Cervical Fluids Are a Source of Protein Biomarkers for Early, Non-Invasive Endometrial Cancer Diagnosis
Cervical Fluids Are a Source of Protein Biomarkers for Early, Non-Invasive Endometrial Cancer Diagnosis Open
Background: Abnormal uterine bleeding is the main symptom of endometrial cancer (EC), but it is highly nonspecific. This represents a huge burden for women’s health since all women presenting with bleeding will undergo sequential invasive …
View article: Noninvasive detection of microsatellite instability in patients with endometrial cancer
Noninvasive detection of microsatellite instability in patients with endometrial cancer Open
The analysis of mismatch repair proteins in solid tissue is the standard of care (SoC) for the microsatellite instability (MSI) characterization in endometrial cancer (EC). Uterine aspirates (UAs) or circulating‐DNA (cfDNA) samples capture…
View article: Aggressive angiomyxoma of the pelvis and vagina: a robotic and vaginal combined approach
Aggressive angiomyxoma of the pelvis and vagina: a robotic and vaginal combined approach Open
View article: 2022-RA-1509-ESGO The MULTISENT study: Analysis of survival according to the volume of sentinel lymph node disease
2022-RA-1509-ESGO The MULTISENT study: Analysis of survival according to the volume of sentinel lymph node disease Open
View article: 2022-RA-964-ESGO Radioguided occult lesion localisation (ROLL) for gynecologic tumor relapses: development of a technique
2022-RA-964-ESGO Radioguided occult lesion localisation (ROLL) for gynecologic tumor relapses: development of a technique Open
View article: 2022-RA-1475-ESGO Impact of molecular profiling on endometrial cancer staging: towards a personalized surgery
2022-RA-1475-ESGO Impact of molecular profiling on endometrial cancer staging: towards a personalized surgery Open
Introduction/Background Molecular profiling in endometrial cancer(EC) is a consistent information that we may obtain from the pre-operative specimen. Nevertheless, its use for making surgical decisions has been barely explored. We aimed to…
View article: 2022-RA-1250-ESGO The MULTISENT study: a multicenter study about the sentinel lymph node biopsy in clinical stage I and II endometrial cancer
2022-RA-1250-ESGO The MULTISENT study: a multicenter study about the sentinel lymph node biopsy in clinical stage I and II endometrial cancer Open
View article: 2022-RA-997-ESGO Lung recurrence of endometrial adenocarcinoma: impact of molecular profile and role of local therapies on prognosis
2022-RA-997-ESGO Lung recurrence of endometrial adenocarcinoma: impact of molecular profile and role of local therapies on prognosis Open
View article: Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool
Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool Open
Endometrial cancer (EC) is the second most frequent gynecological cancer worldwide. Although improvements in EC classification have enabled an accurate establishment of disease prognosis, women with a high-risk or recurrent EC face a drama…
View article: Giant primary hepatic lymphoma. About a case
Giant primary hepatic lymphoma. About a case Open
El linfoma hepático primario es una forma inusual de linfoma no Hodgkin que suele manifestarse clÃnicamente con sÃntomas constitutivos, hepatomegalia e ictericia con patrón colestásico, sin presencia de adenomegalias o invasión extra…
View article: In silico Approach for Validating and Unveiling New Applications for Prognostic Biomarkers of Endometrial Cancer
In silico Approach for Validating and Unveiling New Applications for Prognostic Biomarkers of Endometrial Cancer Open
Endometrial cancer (EC) mortality is directly associated with the presence of prognostic factors. Current stratification systems are not accurate enough to predict the outcome of patients. Therefore, identifying more accurate prognostic EC…
View article: 873 Pap-smears allow the identification of protein biomarkers to diagnose endometrial cancer
873 Pap-smears allow the identification of protein biomarkers to diagnose endometrial cancer Open
Introduction/Background* Endometrial cancer (EC) is the most common gynecological cancer in developed countries. There are no screening tools for its early diagnosis, and the diagnostic process starts with the apparition of related symptom…
View article: 860 Combined use of ICG and technetium does not improve sentinel lymph node detection in endometrial cancer
860 Combined use of ICG and technetium does not improve sentinel lymph node detection in endometrial cancer Open
Introduction/Background* There is scarce evidence available about the benefit of combining technetium (99mTc) and indocyanine green (ICG) for sentinel lymph node (SLN) biopsy in endometrial cancer. The aim of this study was to compare the …
View article: 537 FERTility sparing treatment in patients with ENdometrial Cancer (FERT-ENC) from the Spanish Investigational Network Gynecologic Oncology Group
537 FERTility sparing treatment in patients with ENdometrial Cancer (FERT-ENC) from the Spanish Investigational Network Gynecologic Oncology Group Open
Introduction/Background* The primary objective was to evaluate the response rate of conservative treatment in endometrial cancer and the secondary objective was to assess oncological, fertility and obstetric outcomes in fertility preservat…
View article: 526 STELLA-2 trial: surgical complications comparing extraperitoneal vs transperitoneal mis aortic staging in early stage ovarian and endometrial cancer
526 STELLA-2 trial: surgical complications comparing extraperitoneal vs transperitoneal mis aortic staging in early stage ovarian and endometrial cancer Open
Introduction/Background* The surgical approach of minimally invasive surgery (MIS) for paraaortic staging lymphadenectomy (PALND) in gynecologic malignancies is controversial. The STELLA-2 trial was designed to determine whether the extrap…
View article: Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer Open
View article: Surgical complications comparing extraperitoneal vs transperitoneal laparoscopic aortic staging in early stage ovarian and endometrial cancer
Surgical complications comparing extraperitoneal vs transperitoneal laparoscopic aortic staging in early stage ovarian and endometrial cancer Open